Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy
Open Access
- 1 October 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (10) , 1289-1294
- https://doi.org/10.1023/a:1008375016038
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalitiesLeukemia, 1998
- Therapy-Related Acute Myelogenous Leukemia Associated with 11q23 Chromosomal Abnormalities and Topoisomerase II Inhibitors: Report of Four Additional Cases and Brief CommentaryLeukemia & Lymphoma, 1993
- Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast CancerNew England Journal of Medicine, 1992
- Cellular uptake and tubulin binding properties of four vinca alkaloidsBiochemical Pharmacology, 1992
- Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast CancerJNCI Journal of the National Cancer Institute, 1991
- MitoxantroneDrugs, 1991
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASEThe Lancet, 1987
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958